Intranasal Introduction of Fc-Fused Interleukin-7 Provides Long-Lasting Prophylaxis against Lethal Influenza Virus Infection.

MLA

Kang, Moon Cheol, et al. “Intranasal Introduction of Fc-Fused Interleukin-7 Provides Long-Lasting Prophylaxis against Lethal Influenza Virus Infection.” Journal of Virology, vol. 90, no. 5, Dec. 2015, pp. 2273–84. EBSCOhost, https://doi.org/10.1128/JVI.02768-15.

APA

Kang, M. C., Choi, D.-H., Choi, Y. W., Park, S. J., Namkoong, H., Park, K. S., Ahn, S.-S., Surh, C. D., Yoon, S.-W., Kim, D.-J., Choi, J., Park, Y., Sung, Y. C., & Lee, S.-W. (2015). Intranasal Introduction of Fc-Fused Interleukin-7 Provides Long-Lasting Prophylaxis against Lethal Influenza Virus Infection. Journal of Virology, 90(5), 2273–2284. https://doi.org/10.1128/JVI.02768-15

Chicago

Kang, Moon Cheol, Dong-Hoon Choi, Young Woo Choi, Seong Jeong Park, Hong Namkoong, Ki Seok Park, So-Shin Ahn, et al. 2015. “Intranasal Introduction of Fc-Fused Interleukin-7 Provides Long-Lasting Prophylaxis against Lethal Influenza Virus Infection.” Journal of Virology 90 (5): 2273–84. doi:10.1128/JVI.02768-15.